Lowest float COVID-19 plays I've found from searching trial/fda/news daily:

< 5m
$ABIO $INMB $EDSA $BLPH $ARDS

< 10m
$ACER $IMUX $POAI $BMRA $ATOS $PDSB $CLBS

< 20m
$SINT $KLDO $XAIR $CEMI $EVLO $IFRX $TRIB

< 30m
$RDHL $ANIX $BSGM $PHAS $CHFS

Who's your low float $ on?

Sharing all this in a non-bias way in effort to crowdsource information and catalyst dates I've missed on COVID-19 low float plays. Good / bad - don't hold back.

Attempting to extract value from all the meaningless 'pump' tweets on each ticker - can't do it alone!

<5m

$ABIO AB201 IND submission Q3
$INMB Quellor IND approval Q3
$EDSA EB05 IND approval Q3
$BLPH INOpulse nitric oxide trial data / multiple locs
$ARDS AR-301 trial data overdue
$IDGX Overdue PR for antibody test service COVIANT

<10M

$ACER Emetine IND sub Q3
$IMUX IMU-838 trial ongoing
$POAI NSP10-based vax funding
$BMRA EUA for lab+rapid test. Q2 sales boost
$ATOS C19 Nasal Spray / AT-H201 pre-IND feedback
$PDSB PDS0203 NIAID vax updates
$CLBS CLBS119 lung damage updates

<20m

$SINT antimicrobial n95 masks (speculation)
$KLDO KB109 trial updates, data Q4
$XAIR LungFit trial updates
$CEMI BARDA funded, rapid test approval, OUS sales
$EVLO EP1815 UK trial data, IND hold clearance
$IFRX IFX-1 Phase III data / journal
$TRIB Rapid + lab test approval

<30m

$RDHL Opaganib US approval / positive OUS data already
$ANIX Vaccine + therapy discovery updates
$BSGM Merimepodib may improve remdesivir outcomes, trial ongoing
$PHAS PB1046 phase 2 ARDS trial updates
$CHFS aquadex SmartFlow trial updates

Screener link:
https://elite.finviz.com/screener.ashx?v=131&t=BMRA,ATOS,BSGM,PDSB,INMB,EDSA,ACER,BLPH,ABIO,ARDS,IMUX,POAI,CPIX,TRIB,CLBS,ANIX,RDHL,PHAS,KLDO,CHFS,EVLO,CEMI,IFRX,XAIR,SINT&o=change

If I'm missing any low float COVID-19 plays let me know.

This is a small selection of well over 200+ stocks I'm watching with COVID-19 activity but floats are high. This just narrows things down by probably of high returns.

Can't watch everything. @ me with anything you find, dates, studies, catalysts, hard data. Particularly good/bad chart setups and incoming volume or insider trades noticed.

Any help is appreciated! Just reply to the Tweet with the right ticker to help keep organised.

Update 1 (missing from main list)

$SBPH NIH compound feedback
$ASTC updates on breathalyzers for covid detection
$IDXG Covid19 lab testing service
$AIM Ampligen trial starting / updates

With thanks to @Higgins14Steve and aveyn on atlas

Update 2 (missing from main list)

$IMRN IMM-124E shows neutralizing activity in lab studies, pending further updates
$CANF Piclidenoson expected IND filing before end of July
$CYCC Fadraciclib and Seliciclib trial updates

With thanks to @TradeHawk, @riqchang, @defi_me